The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state

Gastro-retentive dosage forms have the potential to improve local therapy and decrease the variation in bioavailability that is observed with a number of commercially available immediate and modified release preparations. In this study, a dosage form has been developed, utilising freeze-dried calciu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2006-02, Vol.308 (1), p.8-13
Hauptverfasser: Stops, Frances, Fell, John T., Collett, John H., Martini, Luigi G., Sharma, Harbans L., Smith, Anne-Marie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 13
container_issue 1
container_start_page 8
container_title International journal of pharmaceutics
container_volume 308
creator Stops, Frances
Fell, John T.
Collett, John H.
Martini, Luigi G.
Sharma, Harbans L.
Smith, Anne-Marie
description Gastro-retentive dosage forms have the potential to improve local therapy and decrease the variation in bioavailability that is observed with a number of commercially available immediate and modified release preparations. In this study, a dosage form has been developed, utilising freeze-dried calcium alginate beads, designed to float on the surface of the stomach contents thus prolonging the retention time. The aim of the study was to also assess the in vivo behaviour of the radio-labelled calcium alginate beads when they were administered under fasting conditions with either water or an aqueous solution of citric acid, a potential gut transit delaying substance. The study was performed in healthy male volunteers who swallowed the radio-labelled calcium alginate beads after a 10 h overnight fast. Gamma scintigraphy was selected as the method to monitor the movement of the calcium alginate beads. The volunteers consumed no further food or drink until gastric emptying of the calcium alginate beads was complete. The results indicated that prolonged gastric retention was achieved when the dosage form was administered with the citric acid solution when compared to retention in the absence of citric acid. Citric acid, therefore, has the potential to delay the gastric emptying of the calcium alginate beads when administered to fasted volunteers.
doi_str_mv 10.1016/j.ijpharm.2005.09.036
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70686148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517305007088</els_id><sourcerecordid>70686148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-45b6dc02e00ea1702749e9545325587ff0e1e1f9f33e48ff5b3828446b2cbb3f3</originalsourceid><addsrcrecordid>eNqFkD2P1DAQQC0E4paDnwByA13COP6IUyF04ks6ieaoLccZ73mVjRfbuxL__hxtpCup3Lw3M36EvGfQMmDq86ENh9OjTce2A5AtDC1w9YLsmO55w0WvXpId8F43kvX8hrzJ-QAAqmP8NblhinPNQO_I_PCI9JyRRk9dKCk4al2YaIn0lOIclz0tlQgLvYRLpHubS4pNwoJLCXFZNUv9HG0JFZ1itnukPqbjqqymrwZONBdb8C155e2c8d323pI_37893P1s7n__-HX39b5xQg6lEXJUk4MOAdCyHrpeDDhIIXknpe69B2TI_OA5R6G9lyPXnRZCjZ0bR-75Lfl0nVu_8PeMuZhjyA7n2S4Yz9n0oLRiQldQXkGXYs4JvTmlcLTpn2Fg1szmYLbMZs1sYDA1c_U-bAvO4xGnZ2vrWoGPG2Czs7NPdnEhP3O94IMCqNyXK4c1xyVgMtkFXBxOIaErZorhP6c8ARAOngs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70686148</pqid></control><display><type>article</type><title>The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Stops, Frances ; Fell, John T. ; Collett, John H. ; Martini, Luigi G. ; Sharma, Harbans L. ; Smith, Anne-Marie</creator><creatorcontrib>Stops, Frances ; Fell, John T. ; Collett, John H. ; Martini, Luigi G. ; Sharma, Harbans L. ; Smith, Anne-Marie</creatorcontrib><description>Gastro-retentive dosage forms have the potential to improve local therapy and decrease the variation in bioavailability that is observed with a number of commercially available immediate and modified release preparations. In this study, a dosage form has been developed, utilising freeze-dried calcium alginate beads, designed to float on the surface of the stomach contents thus prolonging the retention time. The aim of the study was to also assess the in vivo behaviour of the radio-labelled calcium alginate beads when they were administered under fasting conditions with either water or an aqueous solution of citric acid, a potential gut transit delaying substance. The study was performed in healthy male volunteers who swallowed the radio-labelled calcium alginate beads after a 10 h overnight fast. Gamma scintigraphy was selected as the method to monitor the movement of the calcium alginate beads. The volunteers consumed no further food or drink until gastric emptying of the calcium alginate beads was complete. The results indicated that prolonged gastric retention was achieved when the dosage form was administered with the citric acid solution when compared to retention in the absence of citric acid. Citric acid, therefore, has the potential to delay the gastric emptying of the calcium alginate beads when administered to fasted volunteers.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2005.09.036</identifier><identifier>PMID: 16338108</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adult ; Alginate ; Alginates - administration &amp; dosage ; Alginates - chemistry ; Beads ; Biological and medical sciences ; Citric acid ; Citric Acid - pharmacology ; Delayed-Action Preparations ; Drug Carriers - administration &amp; dosage ; Fasting ; Floating dosage forms ; Gastric Emptying - drug effects ; Gastric retention ; Gastrointestinal Tract - diagnostic imaging ; Gastrointestinal Transit - drug effects ; General pharmacology ; Glucuronic Acid - administration &amp; dosage ; Glucuronic Acid - chemistry ; Hexuronic Acids - administration &amp; dosage ; Hexuronic Acids - chemistry ; Humans ; Hydrogen-Ion Concentration ; Male ; Medical sciences ; Middle Aged ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Radionuclide Imaging ; Radiopharmaceuticals ; Scintigraphy ; Sodium Pertechnetate Tc 99m ; Solubility ; Surface Properties</subject><ispartof>International journal of pharmaceutics, 2006-02, Vol.308 (1), p.8-13</ispartof><rights>2005 Elsevier B.V.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-45b6dc02e00ea1702749e9545325587ff0e1e1f9f33e48ff5b3828446b2cbb3f3</citedby><cites>FETCH-LOGICAL-c459t-45b6dc02e00ea1702749e9545325587ff0e1e1f9f33e48ff5b3828446b2cbb3f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378517305007088$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17439600$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16338108$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stops, Frances</creatorcontrib><creatorcontrib>Fell, John T.</creatorcontrib><creatorcontrib>Collett, John H.</creatorcontrib><creatorcontrib>Martini, Luigi G.</creatorcontrib><creatorcontrib>Sharma, Harbans L.</creatorcontrib><creatorcontrib>Smith, Anne-Marie</creatorcontrib><title>The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Gastro-retentive dosage forms have the potential to improve local therapy and decrease the variation in bioavailability that is observed with a number of commercially available immediate and modified release preparations. In this study, a dosage form has been developed, utilising freeze-dried calcium alginate beads, designed to float on the surface of the stomach contents thus prolonging the retention time. The aim of the study was to also assess the in vivo behaviour of the radio-labelled calcium alginate beads when they were administered under fasting conditions with either water or an aqueous solution of citric acid, a potential gut transit delaying substance. The study was performed in healthy male volunteers who swallowed the radio-labelled calcium alginate beads after a 10 h overnight fast. Gamma scintigraphy was selected as the method to monitor the movement of the calcium alginate beads. The volunteers consumed no further food or drink until gastric emptying of the calcium alginate beads was complete. The results indicated that prolonged gastric retention was achieved when the dosage form was administered with the citric acid solution when compared to retention in the absence of citric acid. Citric acid, therefore, has the potential to delay the gastric emptying of the calcium alginate beads when administered to fasted volunteers.</description><subject>Adult</subject><subject>Alginate</subject><subject>Alginates - administration &amp; dosage</subject><subject>Alginates - chemistry</subject><subject>Beads</subject><subject>Biological and medical sciences</subject><subject>Citric acid</subject><subject>Citric Acid - pharmacology</subject><subject>Delayed-Action Preparations</subject><subject>Drug Carriers - administration &amp; dosage</subject><subject>Fasting</subject><subject>Floating dosage forms</subject><subject>Gastric Emptying - drug effects</subject><subject>Gastric retention</subject><subject>Gastrointestinal Tract - diagnostic imaging</subject><subject>Gastrointestinal Transit - drug effects</subject><subject>General pharmacology</subject><subject>Glucuronic Acid - administration &amp; dosage</subject><subject>Glucuronic Acid - chemistry</subject><subject>Hexuronic Acids - administration &amp; dosage</subject><subject>Hexuronic Acids - chemistry</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Radionuclide Imaging</subject><subject>Radiopharmaceuticals</subject><subject>Scintigraphy</subject><subject>Sodium Pertechnetate Tc 99m</subject><subject>Solubility</subject><subject>Surface Properties</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD2P1DAQQC0E4paDnwByA13COP6IUyF04ks6ieaoLccZ73mVjRfbuxL__hxtpCup3Lw3M36EvGfQMmDq86ENh9OjTce2A5AtDC1w9YLsmO55w0WvXpId8F43kvX8hrzJ-QAAqmP8NblhinPNQO_I_PCI9JyRRk9dKCk4al2YaIn0lOIclz0tlQgLvYRLpHubS4pNwoJLCXFZNUv9HG0JFZ1itnukPqbjqqymrwZONBdb8C155e2c8d323pI_37893P1s7n__-HX39b5xQg6lEXJUk4MOAdCyHrpeDDhIIXknpe69B2TI_OA5R6G9lyPXnRZCjZ0bR-75Lfl0nVu_8PeMuZhjyA7n2S4Yz9n0oLRiQldQXkGXYs4JvTmlcLTpn2Fg1szmYLbMZs1sYDA1c_U-bAvO4xGnZ2vrWoGPG2Czs7NPdnEhP3O94IMCqNyXK4c1xyVgMtkFXBxOIaErZorhP6c8ARAOngs</recordid><startdate>20060203</startdate><enddate>20060203</enddate><creator>Stops, Frances</creator><creator>Fell, John T.</creator><creator>Collett, John H.</creator><creator>Martini, Luigi G.</creator><creator>Sharma, Harbans L.</creator><creator>Smith, Anne-Marie</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060203</creationdate><title>The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state</title><author>Stops, Frances ; Fell, John T. ; Collett, John H. ; Martini, Luigi G. ; Sharma, Harbans L. ; Smith, Anne-Marie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-45b6dc02e00ea1702749e9545325587ff0e1e1f9f33e48ff5b3828446b2cbb3f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Alginate</topic><topic>Alginates - administration &amp; dosage</topic><topic>Alginates - chemistry</topic><topic>Beads</topic><topic>Biological and medical sciences</topic><topic>Citric acid</topic><topic>Citric Acid - pharmacology</topic><topic>Delayed-Action Preparations</topic><topic>Drug Carriers - administration &amp; dosage</topic><topic>Fasting</topic><topic>Floating dosage forms</topic><topic>Gastric Emptying - drug effects</topic><topic>Gastric retention</topic><topic>Gastrointestinal Tract - diagnostic imaging</topic><topic>Gastrointestinal Transit - drug effects</topic><topic>General pharmacology</topic><topic>Glucuronic Acid - administration &amp; dosage</topic><topic>Glucuronic Acid - chemistry</topic><topic>Hexuronic Acids - administration &amp; dosage</topic><topic>Hexuronic Acids - chemistry</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Radionuclide Imaging</topic><topic>Radiopharmaceuticals</topic><topic>Scintigraphy</topic><topic>Sodium Pertechnetate Tc 99m</topic><topic>Solubility</topic><topic>Surface Properties</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stops, Frances</creatorcontrib><creatorcontrib>Fell, John T.</creatorcontrib><creatorcontrib>Collett, John H.</creatorcontrib><creatorcontrib>Martini, Luigi G.</creatorcontrib><creatorcontrib>Sharma, Harbans L.</creatorcontrib><creatorcontrib>Smith, Anne-Marie</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stops, Frances</au><au>Fell, John T.</au><au>Collett, John H.</au><au>Martini, Luigi G.</au><au>Sharma, Harbans L.</au><au>Smith, Anne-Marie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2006-02-03</date><risdate>2006</risdate><volume>308</volume><issue>1</issue><spage>8</spage><epage>13</epage><pages>8-13</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Gastro-retentive dosage forms have the potential to improve local therapy and decrease the variation in bioavailability that is observed with a number of commercially available immediate and modified release preparations. In this study, a dosage form has been developed, utilising freeze-dried calcium alginate beads, designed to float on the surface of the stomach contents thus prolonging the retention time. The aim of the study was to also assess the in vivo behaviour of the radio-labelled calcium alginate beads when they were administered under fasting conditions with either water or an aqueous solution of citric acid, a potential gut transit delaying substance. The study was performed in healthy male volunteers who swallowed the radio-labelled calcium alginate beads after a 10 h overnight fast. Gamma scintigraphy was selected as the method to monitor the movement of the calcium alginate beads. The volunteers consumed no further food or drink until gastric emptying of the calcium alginate beads was complete. The results indicated that prolonged gastric retention was achieved when the dosage form was administered with the citric acid solution when compared to retention in the absence of citric acid. Citric acid, therefore, has the potential to delay the gastric emptying of the calcium alginate beads when administered to fasted volunteers.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>16338108</pmid><doi>10.1016/j.ijpharm.2005.09.036</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2006-02, Vol.308 (1), p.8-13
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_70686148
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Alginate
Alginates - administration & dosage
Alginates - chemistry
Beads
Biological and medical sciences
Citric acid
Citric Acid - pharmacology
Delayed-Action Preparations
Drug Carriers - administration & dosage
Fasting
Floating dosage forms
Gastric Emptying - drug effects
Gastric retention
Gastrointestinal Tract - diagnostic imaging
Gastrointestinal Transit - drug effects
General pharmacology
Glucuronic Acid - administration & dosage
Glucuronic Acid - chemistry
Hexuronic Acids - administration & dosage
Hexuronic Acids - chemistry
Humans
Hydrogen-Ion Concentration
Male
Medical sciences
Middle Aged
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Radionuclide Imaging
Radiopharmaceuticals
Scintigraphy
Sodium Pertechnetate Tc 99m
Solubility
Surface Properties
title The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T09%3A29%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20use%20of%20citric%20acid%20to%20prolong%20the%20in%20vivo%20gastro-retention%20of%20a%20floating%20dosage%20form%20in%20the%20fasted%20state&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Stops,%20Frances&rft.date=2006-02-03&rft.volume=308&rft.issue=1&rft.spage=8&rft.epage=13&rft.pages=8-13&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/j.ijpharm.2005.09.036&rft_dat=%3Cproquest_cross%3E70686148%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70686148&rft_id=info:pmid/16338108&rft_els_id=S0378517305007088&rfr_iscdi=true